Highly Specific Zika Neutralizing Human Antibodies
Copyright © Targeted News Service 2026
2026-01-27
ALEXANDRIA, Virginia, Jan. 27 -- THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, Chapel Hill, North Carolina has been assigned a patent (No. US 12534517 B2, initially filed Nov. 21, 2018) developed by five inventors Sean Diehl, Shelburne, Vermont; Aravinda de Silva, Chapel Hill, North Carolina; Matthew Collins, Chapel Hill, North Carolina; Ben McElvany, Burlington, Vermont; and Huy Tu, Burlington, Vermont, for "Highly specific zika neutralizing human antibodies." . . .
